Recombinant Human AKR1C4 Protein，His

AKR1C4, or Aldo-Keto Reductase Family 1 Member C4, is a crucial enzyme involved in the metabolism of steroid hormones and xenobiotics, playing a significant role in various physiological processes. This enzyme is encoded by the AKR1C4 gene and is primarily expressed in the liver, kidneys, and reproductive tissues. It catalyzes the reduction of ketones and aldehydes, contributing to the biosynthesis of important steroid hormones like progesterone and testosterone, as well as the detoxification of harmful aldehydes. Research into AKR1C4 has gained traction in recent years due to its implications in various diseases, particularly its association with cancer progression, especially in hormone-dependent tumors. Elevated levels of AKR1C4 have been linked to poor prognosis in breast and prostate cancers, highlighting its potential as a biomarker for disease progression and a target for therapeutic intervention. Moreover, understanding its structure and enzymatic mechanism can aid in the design of selective inhibitors that could mitigate its role in tumor growth. The production of recombinant AKR1C4 proteins for biochemical studies is thus essential for elucidating its function, regulation, and potential as a drug target. Such studies not only contribute to the understanding of steroid metabolism and hormone regulation but also pave the way for novel therapeutic strategies against cancers and other disorders linked to enzyme dysregulation. Consequently, ongoing research into AKR1C4 will enhance our comprehension of its biological significance and its potential application in clinical settings.